BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38704830)

  • 1. Downregulation of lncRNA MIR17HG reduced tumorigenicity and Treg-mediated immune escape of non-small-cell lung cancer cells through targeting the miR-17-5p/RUNX3 axis.
    Zheng G; Ye H; Bai J; Zhang X
    J Biochem Mol Toxicol; 2024 May; 38(5):e23715. PubMed ID: 38704830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding HOXA11-AS knockdown suppresses the progression of non-small cell lung cancer by regulating miR-3619-5p/SALL4 axis.
    Xia H; Niu Q; Ding Y; Zhang Z; Yuan J; Jin W
    J Mol Histol; 2021 Aug; 52(4):729-740. PubMed ID: 34050851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal Transducer and Activator of Transcription 4-Induced Up-Regulated LINC01278 Enhances Proliferation and Invasion of Non-Small Cell Lung Cancer Cells via the MicroRNA-877-5p/Activating Transcription Factor 4 Axis.
    Yang L; Xiao Y; Deng S; Yan D; Li Z; Wang Y; Lei C
    Tissue Eng Regen Med; 2024 Jun; 21(4):595-608. PubMed ID: 38466361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC.
    Wang H; Wang L; Zhang S; Xu Z; Zhang G
    Biomed Pharmacother; 2020 Jul; 127():110214. PubMed ID: 32403047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p/MDM4 axis.
    Wang D; Zhang S; Zhao M; Chen F
    Cancer Med; 2020 Dec; 9(23):9138-9149. PubMed ID: 33146951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0006988 promotes the proliferation, metastasis and angiogenesis of non-small cell lung cancer cells by modulating miR-491-5p/MAP3K3 axis.
    Yang C; Shi J; Wang J; Hao D; An J; Jiang J
    Cell Cycle; 2021 Jul; 20(13):1334-1346. PubMed ID: 34189997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA CCAT1 promotes non-small cell lung cancer progression by regulating the miR-216a-5p/RAP2B axis.
    Pang L; Zhang Q; Wu Y; Yang Q; Zhang J; Liu Y; Li R
    Exp Biol Med (Maywood); 2021 Jan; 246(2):142-152. PubMed ID: 33023331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
    Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
    Liu L; Chen Y; Li Q; Duan P
    J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
    Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
    Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L; Cheng Y; Zou S; Song J
    Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer.
    Wei K; Pan C; Yao G; Liu B; Ma T; Xia Y; Jiang W; Chen L; Chen Y
    Cell Physiol Biochem; 2017; 44(4):1545-1558. PubMed ID: 29197876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer.
    Song J; Liu Y; Wang T; Li B; Zhang S
    Biomed Pharmacother; 2020 Aug; 128():110246. PubMed ID: 32447210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D; Wang Y; Ren K; Han X
    Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
    Song J; Su ZZ; Shen QM
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis.
    Xu Y; Zhao R; Wang H; Jiang J; Wang Z; Wang J; Zhang W; Li M
    J BUON; 2021; 26(5):1850-1861. PubMed ID: 34761592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
    He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
    Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.